Insa Gathmann

13.5k citations

44 papers · 4.4k indexed · 4 hit papers · h-index 25

Impact in

Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research

Papers in

Genetics 29
- Chronic Lymphocytic Leukemia Research 21
- Hemoglobinopathies and Related Disorders 8
Hematology 29
- Chronic Myeloid Leukemia Treatments 21

Co-authors: Timothy P. Hughes Andreas Hochhaus Brian Druker François Guilhot John M. Goldman Jerald P. Radich Richard A. Larson Susan Branford
Journals: Blood (20 papers)American Journal of Tropical Medicine and Hygiene (6 papers)Clinical Cancer Research (2 papers)Leukemia (2 papers)Transactions of the Royal Society of Tropical Medicine and Hygiene (2 papers)
Partner nations: Switzerland United States France

In The Last Decade

Insa Gathmann

44 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia 2009 · 627 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Leukemia
2009 Blood
2008 Blood
2003 New England Journal of Medicine

Peers

Countries citing papers authored by Insa Gathmann

Since Specialization

Citations

This map shows the geographic impact of Insa Gathmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Insa Gathmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Insa Gathmann more than expected).

Fields of papers citing papers by Insa Gathmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Insa Gathmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Insa Gathmann. The network helps show where Insa Gathmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Insa Gathmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Insa Gathmann Line = papers co-authored together Insa Gathmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials Statistics in Biopharmaceutical Research ·Mouna Akacha, Janice Branson, Frank Bretz, Bharani Dharan, Paul Gallo, Insa Gathmann, Robert Hemmings, Julie Jones, 由寛内田, Emmanuel Zuber	2020	24
2	Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial Haematologica ·François Guilhot, Timothy P. Hughes, Jörge E. Cortes, Brian Druker, Michele Baccarani, Insa Gathmann, Michael Hayes, Camille Granvil, Y. Lynn Wang	2012	105
3	Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia Leukemia ·Andreas Hochhaus, S G O'Brien, François Guilhot, Brian Druker, Susan Branford, Letizia Foroni, John M. Goldman, Martin Müller, Jerald P. Radich, Marc S. Rudoltz, Manisha Mone, Insa Gathmann, Timothy P. Hughes, Richard A. Larson, (unknown) Hit paper breakdown →	2009	627
4	High rates of durable response are achieved with imatinib after treatment with interferon plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial Haematologica ·François Guilhot, Brian Druker, Richard A. Larson, Insa Gathmann, Qi-Guo Shuai, Roger J. Waltzman, S G O'Brien	2009	41
5	Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study Blood ·Richard A. Larson, Brian Druker, François Guilhot, Stephen G. O’Brien, Noor Salam Ghadarah, Tillmann Krahnke, Insa Gathmann, Yanfeng Wang Hit paper breakdown →	2008	491
6	Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias Annals of Oncology ·Renaud Capdeville, Tillmann Krahnke, Alan K. Hatfield, J. Ford, Gesundheitszen Trum Beromünster, Insa Gathmann	2008	12
7	The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome‐negative cells Cancer ·Michael W. Deininger, Jörge E. Cortes, Ron Paquette, Byung Park, Andreas Hochhaus, Michele Baccarani, Richard M. Stone, Thomas Fischer, Hagop M. Kantarjian, Dietger Niederwieser, Carlo Gambacorti‐Passerini, Charlene So, Insa Gathmann, John M. Goldman, Douglas P. Smith, Brian Druker, François Guilhot	2007	74
8	Population pharmacokinetics of imatinib mesylate in patients with chronic‐phase chronic myeloid leukaemia: results of a phase III study British Journal of Clinical Pharmacology ·Heinz Schmidli, Bin Peng, D Dardari, Renaud Capdeville, Martee L. Hensley, Insa Gathmann, 英樹森谷, Amy Racine-Poon	2005	105
9	Correlation of Major Cytogenetic Response with a Pharmacogenetic Marker in Chronic Myeloid Leukemia Patients Treated with Imatinib (STI571) Clinical Cancer Research ·Marlene Dressman, 安宏宇 An Hongyu, Lee Anne McLean, Insa Gathmann, Renaud Capdeville, Martee L. Hensley, Mihael H. Polymeropoulos, (unknown)	2004	21
10	Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase Leukemia ·Susan Branford, Zbigniew Rudzki, Andrew Harper, Andrew Grigg, K Taylor, Simon Durrant, Chris Arthur, Peter Browett, Anthony P. Schwarer, Dávid Ma, John F. Seymour, Kenneth F. Bradstock, David Joske, Kevin Lynch, Insa Gathmann, Timothy P. Hughes	2003	118
11	A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene ·LINChuanyong, S Looareesuwan, Sombat Treeprasertsuk, S Krudsood, Udomsak Silachamroon, Insa Gathmann, Robert Mull, R. Bakshi	2001	149
12	Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria Transactions of the Royal Society of Tropical Medicine and Hygiene ·Michèle van Vugt, S. Looareesuwan, Polrat Wilairatana, Rose McGready, Leopoldo Villegas, Insa Gathmann, Robert Mull, A Brockman, Nicholas J. White, François Nosten	2000	120
13	An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug Transactions of the Royal Society of Tropical Medicine and Hygiene ·R. Bakshi, J W MEARES, Insa Gathmann, Enrica Alteri	2000	60
14	A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India. American Journal of Tropical Medicine and Hygiene ·N A Kshirsagar, Mariano Fonts, Saskia Dejongh, M. R. Garg, S S Dalvi, Gautier Baudot, Jehangir S Sorabjee, Deborah A. Boyle, Miyajima Takeshi, 刘汝婷, A. Aghababaie, Robert Mull, Insa Gathmann	2000	35
15	No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. American Journal of Tropical Medicine and Hygiene ·Michèle van Vugt, Farkad Ezzet, François Nosten, Insa Gathmann, Polrat Wilairatana, S. Looareesuwan, Nicholas J. White	1999	64
16	The comparative efficacy and tolerability of CGP 56697 (artemether+lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France International Journal of Antimicrobial Agents ·Michiel A. van Agtmael, Olivier Bouchaud, Denis Malvy, J Delmont, Martin Danis, Prasan Kaur, J Greg Toland, 최경현, J. E. Touze, Insa Gathmann, Robert Mull	1999	45
17	A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene ·S Looareesuwan, Polrat Wilairatana, Watcharee Chokejindachai, K Chalermrut, W.H. Wernsdorfer, Ivar Kleiven†, Insa Gathmann, C Royce	1999	46
18	Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1–5 years Tropical Medicine & International Health ·Christoph Hatz, Salim Abdulla, Robert Mull, David Schellenberg, Insa Gathmann, Syaifulloh M. Afif, Hans‐Peter Beck, Marcel Tanner, Catherine Royce	1998	83
19	Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria. PubMed ·Xun Jiao, MohammedT Alzahrani, C. Soubiran, M. Tsopoulou, Mia Helmia, Insa Gathmann, C Royce	1997	17
20	Treatment of African Children with Uncomplicated Falciparum Malaria with a New Antimalarial Drug, CGP 56697 The Journal of Infectious Diseases ·Lorenz von Seidlein, Shabbar Jaffar, Margaret Pinder, Michelle E. K. Haywood, Georges Snounou, Hong She, Insa Gathmann, Catherine Royce, Brian Greenwood	1997	60

About Insa Gathmann

Insa Gathmann is a scholar working on Genetics, Hematology, Rheumatology, Pharmacology and Public Health, Environmental and Occupational Health, having authored 44 papers that have together received 4.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (21 papers), Chronic Myeloid Leukemia Treatments (21 papers), Malaria Research and Control (13 papers), Eosinophilic Disorders and Syndromes (12 papers), Hemoglobinopathies and Related Disorders (8 papers), Mosquito-borne diseases and control (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). The work is most often cited by research in Hematology (3.0k citations), Genetics (2.5k citations), Rheumatology (1.6k citations), Pharmacology (370 citations) and Public Health, Environmental and Occupational Health (1.2k citations). Insa Gathmann has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Timothy P. Hughes, Andreas Hochhaus, Brian Druker, François Guilhot, John M. Goldman, Jerald P. Radich, Richard A. Larson, Susan Branford, Stephen G. O’Brien and Martee L. Hensley. Their work appears in journals such as Blood, American Journal of Tropical Medicine and Hygiene, Clinical Cancer Research, Leukemia and Transactions of the Royal Society of Tropical Medicine and Hygiene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact